Kelyniam Global (OTC: KLYG), a maker of custom cranial implants, today announced results for its year ended December 31, 2022. The complete financials are available here. “2022 was the sixth year in a row that Kelyniam has meaningfully increased sales while successfully competing against much larger competitors” said Ross Bjella, Kelyniam’s CEO. “Neurosurgeons rely on...Read More